BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1607343)

  • 1. Specificity of heme for hemopoietic recovery from AZT toxicity.
    Loewy G; Cook P; Ahmed T; Lutton JD; Nishimura M; Distenfeld A; Levere RD; Abraham NG
    Hematol Pathol; 1992; 6(2):79-85. PubMed ID: 1607343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
    Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
    Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
    Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
    Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of azidothymidine-induced erythroid toxicity by hemin and stem cell factor in immune-suppressed mice.
    Hamburger AW; Chen RB
    Exp Hematol; 1994 Apr; 22(4):348-52. PubMed ID: 7512046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)].
    Arock M; Dedenon A; Damais C; Averlant G; Guillosson JJ
    C R Seances Soc Biol Fil; 1992; 186(3):206-14. PubMed ID: 1493577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
    Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
    Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice.
    Gallicchio VS; Hughes NK; Tse KF; Gaines H
    Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
    Gallicchio VS; Hughes NK
    Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemotoxic effects on mice of combined administration of azidothymidine and acyclovir.
    Bogliolo G; Lerza R; Mencoboni M; Flego G; Gasparini L; Pannacciulli I
    Exp Hematol; 1991 Sep; 19(8):838-41. PubMed ID: 1868898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemopoietic recovery from AZT toxicity with recombinant hemoglobin in a murine model of AIDS.
    Moqattash S; Lutton JD; Abu-Hijleh MF; Abraham NG
    Acta Haematol; 1994; 92(4):182-6. PubMed ID: 7701915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced colony formation of human hemopoietic stem cells in reduced oxygen tension.
    Maeda H; Hotta T; Yamada H
    Exp Hematol; 1986 Nov; 14(10):930-4. PubMed ID: 3770101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of iron and iron carrier on hematopoietic cells differentiation and human ADA gene transfer.
    Abraham NG; Lutton JD
    Adv Exp Med Biol; 1994; 356():199-210. PubMed ID: 7887224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
    Mangan KF; D'Alessandro L; Mullaney MT
    J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.